Targeting Acute Myelogenous Leukemia Using Potent Human

The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting

Frontiers Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia

Cancers, Free Full-Text

Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023

Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia

CD33-directed therapy: Current and future perspectives on targeted therapy in acute myeloid leukaemia (AML)

Biomedicines, Free Full-Text

Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia

Children, Free Full-Text

Cancers, Free Full-Text

Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety

Possible treatment algorithm in relapsed/refractory AML patients. AML =

Cells, Free Full-Text